This, belatedly, is the third installment of my discussion of the court-of-appeals decision in Sherley v. Sebelius, which reversed the lower court’s conclusion that the federal government is forbidden from funding research on human embryonic stem cells. The first two installments are here (part 1) and here (part 2); you should read them first if you haven’t done so already or if they’ve faded from your memory. (As before, I’ll note that I represent the Genetics Policy Institute as an amicus curiae in the case, supporting the government.)
One of the points of disagreement between the majority opinion and the dissent was over how to interpret the Dickey-Wicker Amendment’s use of the present tense (“research in which a human embryo or embryos are destroyed…”). The dispute arises because a line of stem cells derived from a particular embryo can be kept in existence indefinitely and as a result can provide stem cells for research that is performed many years later. For example, under the Bush-administration guidelines, federal funding was available only for research projects that used stem cells that had been derived before August 9, 2001, when the Bush policy was announced. And NIH maintains a registry of stem-cell lines that qualify for use in federally-funded research. There is therefore a good chance that an applicant seeking NIH funds will use stem cells from a preexisting cell line.
The majority rejected the plaintiff’s argument that the government may not fund research using such a preexisting line of stem cells, and in doing so the Dickey-Wicker Amendment’s use of the present tense played a big part:
Continue reading →
This is the second installment of my look at the recent court of appeals decision in Sherley v. Sebelius, the litigation over federal funding of research on human embryonic stem cells (hESCs). The first installment, which sets the stage, is here. And before I begin, let me repeat that I represent the Genetics Policy Institute as an amicus curiae in support of the government in the case, and that some of what I say here will be adapted from my brief.
I ended my last post by noting that one of the points of disagreement between the majority and the dissent was about whether the word research could be understood to denote a “discrete project.” The majority concluded that the word as used in the Dickey-Wicker Amendment could in fact be understood in that way—an understanding under which the focus is on the specific work for which funding is sought:
NIH funding decisions are forward-looking, requiring the NIH to “determine whether what is proposed to be funded meets with its requirements.” Therefore, a grant application to support research that includes the derivation of stem cells would have to be rejected….The definition of research is flexible enough to describe either a discrete project or an extended process, but this flexibility only reinforces our conclusion that the text is ambiguous. [paragraph break deleted]
Continue reading →
The recent decision in Sherley v. Sebelius—the stem-cell case—turns to a great extent on questions of textual interpretation. And the dissent in particular discusses those questions at length, and gets just about everything wrong. This is the first in what will be a series of posts discussing the textual issues and pointing out some of what I consider to be the dissent’s errors.
Two things before we begin. First, a disclosure: I represent the Genetics Policy Institute as one of the amici on the government’s side in this case, and portions of these posts will be adapted from my amicus brief. Second, a point about terminology. Although the Sherley case is often referred to as dealing simply with “stem-cell research,” it actually deals with research involving human embryonic stem-cells. (hESCs). There are other types of stem cells for which research funding is not restricted. (For general background on stem cells, you can start here or here.)
Let’s start, naturally, with the statute. The Dickey-Wicker Amendment has appeared as a rider to annual appropriations bills for the Department of Health and Human Services every year since 1995. It provides:
Continue reading →
In Sherley v. Sebelius, the stem-cell case in which I filed a brief, the court of appeals has overturned the injunction against federal funding of research on human embryonic stem cells. The decision is available here.
The decision was 2-1, and both the majority opinion and the dissent deal with a variety of language-related issues.